Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.

<h4>Purpose</h4>To evaluate the value of DWI in detecting the lesions of pre- and post-radiofrequency ablation (RFA) of the rabbit liver VX2 tumors.<h4>Materials and methods</h4>Twenty-two New Zealand White rabbits were tested. The protocol was approved by the Committee on th...

Full description

Bibliographic Details
Main Authors: Yubao Liu, Ligong Lu, Haosheng Jin, Xiaoming Chen, Zhonglin Zhang, Zaiyi Liu, Changhong Liang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25102074/?tool=EBI
id doaj-edb997b4e70c4b0981a0b326e5f77f71
record_format Article
spelling doaj-edb997b4e70c4b0981a0b326e5f77f712021-03-04T09:09:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0198e10423910.1371/journal.pone.0104239Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.Yubao LiuLigong LuHaosheng JinXiaoming ChenZhonglin ZhangZaiyi LiuChanghong Liang<h4>Purpose</h4>To evaluate the value of DWI in detecting the lesions of pre- and post-radiofrequency ablation (RFA) of the rabbit liver VX2 tumors.<h4>Materials and methods</h4>Twenty-two New Zealand White rabbits were tested. The protocol was approved by the Committee on the Ethics of Animal Experiments. Twenty separate tumor fragments were implanted into the livers of 20 rabbits, the liver was exposed by performing midline laparotomy. 3.0T MR DWI (b = 0, 200, 400, 600, 800,1000 s/mm2) were performed 14-21 days after tumor implantation (mean, 17 days) in the 18 tumor-bearing animals. Then RFA was performed in the 18 tumor-bearing animals and in the two healthy animals. 3.0T MR DWI was performed 7-10 days after RFA (mean, 8 days). Pathology exam was performed immediately after the completion of post- RFA MR imaging. Analyzing the features of MRI and ADC values in the pre- and post- RFA lesions of the VX2 tumors, and histopathologic results were compared with imaging findings.<h4>Results</h4>The difference of ADC value between viable tumor and normal liver parenchyma was significant (P<.001). After RFA, when b = 200, 400, 600, 800, 1000 s/mm2, the differences of ADC values of viable tumor, granulation tissue, necrosis, normal liver parenchyma were significant (P<.001). At the time the animals were sacrificed after RFA and MR imaging, histopathologic results of local viable tumors were found in 9 (50%) of the 18 treated tumors. Macroscopic viable tumors were found at the RFA sites in 3 (17%), all 3 macroscopic viable tumors were visualized at the periphery of the RFA areas.<h4>Conclusions</h4>3.0T MR DWI can be used to follow up the progress of the RFA lesion, it is useful in detecting different tissues after RFA, and it is valuable in the further clinical research.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25102074/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Yubao Liu
Ligong Lu
Haosheng Jin
Xiaoming Chen
Zhonglin Zhang
Zaiyi Liu
Changhong Liang
spellingShingle Yubao Liu
Ligong Lu
Haosheng Jin
Xiaoming Chen
Zhonglin Zhang
Zaiyi Liu
Changhong Liang
Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.
PLoS ONE
author_facet Yubao Liu
Ligong Lu
Haosheng Jin
Xiaoming Chen
Zhonglin Zhang
Zaiyi Liu
Changhong Liang
author_sort Yubao Liu
title Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.
title_short Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.
title_full Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.
title_fullStr Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.
title_full_unstemmed Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T.
title_sort radiofrequency ablation of liver vx2 tumor: experimental results with mr diffusion-weighted imaging at 3.0t.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description <h4>Purpose</h4>To evaluate the value of DWI in detecting the lesions of pre- and post-radiofrequency ablation (RFA) of the rabbit liver VX2 tumors.<h4>Materials and methods</h4>Twenty-two New Zealand White rabbits were tested. The protocol was approved by the Committee on the Ethics of Animal Experiments. Twenty separate tumor fragments were implanted into the livers of 20 rabbits, the liver was exposed by performing midline laparotomy. 3.0T MR DWI (b = 0, 200, 400, 600, 800,1000 s/mm2) were performed 14-21 days after tumor implantation (mean, 17 days) in the 18 tumor-bearing animals. Then RFA was performed in the 18 tumor-bearing animals and in the two healthy animals. 3.0T MR DWI was performed 7-10 days after RFA (mean, 8 days). Pathology exam was performed immediately after the completion of post- RFA MR imaging. Analyzing the features of MRI and ADC values in the pre- and post- RFA lesions of the VX2 tumors, and histopathologic results were compared with imaging findings.<h4>Results</h4>The difference of ADC value between viable tumor and normal liver parenchyma was significant (P<.001). After RFA, when b = 200, 400, 600, 800, 1000 s/mm2, the differences of ADC values of viable tumor, granulation tissue, necrosis, normal liver parenchyma were significant (P<.001). At the time the animals were sacrificed after RFA and MR imaging, histopathologic results of local viable tumors were found in 9 (50%) of the 18 treated tumors. Macroscopic viable tumors were found at the RFA sites in 3 (17%), all 3 macroscopic viable tumors were visualized at the periphery of the RFA areas.<h4>Conclusions</h4>3.0T MR DWI can be used to follow up the progress of the RFA lesion, it is useful in detecting different tissues after RFA, and it is valuable in the further clinical research.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25102074/?tool=EBI
work_keys_str_mv AT yubaoliu radiofrequencyablationoflivervx2tumorexperimentalresultswithmrdiffusionweightedimagingat30t
AT ligonglu radiofrequencyablationoflivervx2tumorexperimentalresultswithmrdiffusionweightedimagingat30t
AT haoshengjin radiofrequencyablationoflivervx2tumorexperimentalresultswithmrdiffusionweightedimagingat30t
AT xiaomingchen radiofrequencyablationoflivervx2tumorexperimentalresultswithmrdiffusionweightedimagingat30t
AT zhonglinzhang radiofrequencyablationoflivervx2tumorexperimentalresultswithmrdiffusionweightedimagingat30t
AT zaiyiliu radiofrequencyablationoflivervx2tumorexperimentalresultswithmrdiffusionweightedimagingat30t
AT changhongliang radiofrequencyablationoflivervx2tumorexperimentalresultswithmrdiffusionweightedimagingat30t
_version_ 1714807490489614336